Cassava Sciences

SAVA

SAVA Cassava Sciences NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    SAVA Chart
    See on advanced chart >

    About

    Cassava Sciences, Inc. is a biopharmaceutical company that develops novel drugs. The company's lead drug candidate is called REMOXY (oxycodone) Extended-Release Capsules CII. REMOXY is a strong painkiller with a unique formulation designed to reduce...
    • Highlight
      A clinical-stage biotechnology company focused on Alzheimer’s disease
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      07/14/2000
    • Established Date
      Invalid Date
    • Full-time Employees
      29
    • Address
      6801 N. Capital of Texas Highway Building 1 Suite 300 Austin TX 78731
    • Tel
      1-512-5012444
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock